IDH mutant glioma: the role of 2HG in seizure production and tumorigenesis

IDH mutant glioma: the role of 2HG in seizure production and tumorigenesis

Saved in:

Bibliographic Details
Main Authors:	Hiroaki Nagashima, Christine Lee, Shunsuke Yamanishi, Kazuhiro Tanaka, Yosuke Fujimoto, Takashi Sasayama, Hiroaki Wakimoto, Daniel Cahill
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Brain Stimulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1935861X24005266
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
by: Ying Pang, et al.
Published: (2025-04-01)

Metabolic reprogramming in mutant IDH1 glioma cells.
by: Jose L Izquierdo-Garcia, et al.
Published: (2015-01-01)

Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment
by: Hurais Malik, et al.
Published: (2024-09-01)

Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy
by: Peng Wang, et al.
Published: (2025-04-01)

Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions
by: Zhenjiang Pan, et al.
Published: (2025-06-01)

Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy
by: Miyu Kikuchi, et al.
Published: (2025-07-01)

Radiomic study on preoperative multi‐modal magnetic resonance images identifies IDH‐mutant TERT promoter‐mutant gliomas
by: Haoyu Wang, et al.
Published: (2023-02-01)

Predicting p53 Status in IDH‐Mutant Gliomas Using MRI‐Based Radiomic Model
by: Jiamin Li, et al.
Published: (2025-08-01)

A dual-genotype IDH-mutant infiltrating glioma, a real oligoastrocytoma in cerebral hemisphere
by: Jing Liu, PhD, et al.
Published: (2025-06-01)

Analysis of cerebrospinal fluid tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adult
by: Michael Youssef, et al.
Published: (2025-09-01)

Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
by: Michael E Berens, et al.
Published: (2019-01-01)

MRI transformer deep learning and radiomics for predicting IDH wild type TERT promoter mutant gliomas
by: Wenju Niu, et al.
Published: (2025-03-01)

Multidisciplinary quantitative and qualitative assessment of IDH-mutant gliomas with full diagnostic deep learning image reconstruction
by: Christer Ruff, et al.
Published: (2024-12-01)

Integrated Analysis of Cuproptosis Regulators Reveals Prognostic Significance and Therapeutic Targets in IDH1 Mutant Glioma
by: Yuxuan Luan, et al.
Published: (2025-03-01)

The Significance of IDH1 Mutations in Tumor-Associated Seizure in 60 Chinese Patients with Low-Grade Gliomas
by: Ruofei Liang, et al.
Published: (2013-01-01)

A rare IDH-Mutant glioma case: insights from single-cell transcriptomic analysis of tumor recurrences
by: Wen Li, et al.
Published: (2025-07-01)

In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination
by: Martin Glas, et al.
Published: (2025-06-01)

IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
by: Alexander Bray, et al.
Published: (2025-01-01)

IDH1(R132H) Immunoexpression in Glioma
by: Nyan Saeed Omer, et al.
Published: (2023-03-01)

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
by: Kristian A. Choate, et al.
Published: (2024-10-01)

Scaffold modification and synthesis routes for targeting mutant IDH 1: a review
by: Vasavi S. Pai, et al.
Published: (2025-07-01)

Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory
by: Emmanuel Mandonnet, et al.
Published: (2024-11-01)

Valproic acid targets IDH1 mutants through alteration of lipid metabolism
by: Lubayna S. Elahi, et al.
Published: (2024-08-01)

Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
by: Cristian Ionut Orasanu, et al.
Published: (2025-02-01)

Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas
by: Taishi Nakase, et al.
Published: (2025-06-01)

Spinal IDH-wildtype glioma: a single center experience of rare disease
by: H. Gull, et al.
Published: (2024-01-01)

Metabolic profiling in TET2 and IDH2 mutant leukemia reveals cardiac adaptation
by: Alia Sadiq, et al.
Published: (2025-06-01)

Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]
by: Zeidan AM, et al.
Published: (2025-07-01)

Prelimimary research on tolerance mechanisms of rice mutant to soil Hg stress
by: ZENG Bin, et al.
Published: (2008-01-01)

Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma
by: Levi van Hijfte, et al.
Published: (2025-01-01)

An eXplainable deep learning model for multi-modal MRI grading of IDH-mutant astrocytomas
by: Hamail Ayaz, et al.
Published: (2024-12-01)

Oncolytic Virotherapy for Relapsed, IDH-Mutant, Grade 3 Astrocytoma: A New Promising Approach – A Case Report
by: Benjamin Gesundheit, et al.
Published: (2025-03-01)

An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice
by: Xianxin Qiu, et al.
Published: (2025-07-01)

Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas
by: Jing Bao, et al.
Published: (2025-05-01)

Enhanced intraoperative visualization of the optic chiasm using contrast-enhanced balanced steady-state free precession imaging during endoscopic transsphenoidal surgery
by: Yosuke Fujimoto, et al.
Published: (2025-07-01)

Predicting IDH and 1p/19q molecular status of gliomas with multi-b values DWI
by: Shanshan Zhao, et al.
Published: (2025-07-01)

Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study
by: Nicolas Goliot, et al.
Published: (2025-08-01)

Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study
by: Bai Xuexue, et al.
Published: (2025-08-01)

The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01)

Symptomatic Epileptic Seizures in Patients with Brain Gliomas
by: D. I. Abzalova, et al.
Published: (2021-11-01)